Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 FY- Text added to 2023 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
AbbVie, acumen, advisor, Aegerion, affirmative, Agennix, Alcobra, Alex, Amgen, analyze, Anesthesiology, AON, aPKC, aPKCi, apprised, Aquilo, ArisGlobal, Army, ascertain, Assertio, assumption, AstraZeneca, atypical, Avenue, azaquinazoline, background, basal, BCC, Bio, Biochemistry, Biology, Biometry, Biopharm, biopharma, Bioscience, biotech, Brunei, BSc, buyer, Cabaletta, Cambodia, Cape, carcinoma, Centocor, Centurion, CEO, CFO, Chair, charity, Charter, chemotherapeutic, Chest, cholesterol, Cidara, Cincinnati, CMC, COBRA, colorectal, comfort, compatible, configure, Confo, Contemporaneously, Continental, COO, Cope, correctly, correlation, Corridor, counsel, Covance, covenant, CRT, CRUK, CSCRI, cyber, CytRx, Danforth, deep, dental, destructive, disability, disfiguring, dissolution, dissolve, downstream, Draupnir, ductal, Duke, East, Elicio, empowered, entail, EuclidSR, evergreen, faculty, familiarity, fatal, Fellow, fellowship, Floor, Flynn, forfeited, fullest, Gastroenterology, GlaxoSmithKline, GSK, Harvard, hC, head, Hedgehog, Hh, Homology, Horse, Humira, immaterial, imminent, Immunology, ImmusanT, implicated, incurrence, Indonesia, inhibitor, inhibitory, INO, insight, intelligence, intimately, involuntarily, iota, Iowa, joining, Jonathan, Joshua, junior, kinase, Lawrence, leader, leadership, leukemia, Licence, Lincoln, linked, Lipitor, London, LPC, lump, lymphoma, Macau, Malaysia, malignancy, malignant, Marine, MBA, MbChB, mentioned, Merck, Mgmt, Microbiology, molecule, month, mouse, multidisciplinary, murine, Myanmar, myeloid, nearest, neck, NEO, Noah, Nominating, nonprofit, nonqualified, North, Norvasc, Novelion, NSCLC, Ocular, Ohmeda, Olin, oncogene, oncogenic, oncology, Oncospherix, outlicensed, outlicensing, ovarian, PA, pancreatic, Park, partly, Pasteur, path, payroll, PDI, peer, pension, permissible, Pfizer, PhRMA, Pittsburgh, PKC, player, plc, plenary, predetermined, premier, presence, proliferation, prong, protein, Psychology, rank, ratification, ratified, rationale, RCC, readout, recapitalization, Redx, refinance, refine, refining, regular, Repatha, repurchase, resolution, retention, Rinvoq, Rock, Rockledge, Rockwell, rounded, Sanofi, save, SCAI, Scheinfeld, School, science, SEISMiC, skin, Skyrizi, slate, Slippery, smoothened, sNDA, solid, spent, spouse, St, Stanford, Stealth, steering, Strobeck, subsidized, succeeding, tab, tasked, TGFbeta, Therapeutix, thieonpyrimidine, Timor, Topaz, Town, Transcelerate, transcription, Transkaryotic, Trevena, tumor, Varian, Ventaira, veteran, viability, Vietnam, Virginia, vision, warehouse, Washington, welfare, Wharton, Wisconsin, Wyeth, xenograft, York, Zyla
Valuein 2022 FY filing- Value in 2023 FY filing
Original filings
Filing view